medigraphic.com

2012, Number 1

<< Back Next >>

Rev Med MD 2012; 3.4 (1)

Nutritional management in type 2 diabetes mellitus and obesity

González HOR

Language: Spanish
References: 57
Page: 22-31
PDF size: 843.18 Kb.


ABSTRACT

There are several types of diabetes mellitus, type 2 being the most common form of this disease; accounting for over 90% of cases of diabetes in most nations and is a major public health problem in our country since several decades ago it obtained the first place in general mortality statistics. On the other hand, obesity is the most common nutritional disorder in the developed world and is reaching significant proportions in developing countries. In the population it´s associated with increased morbidity and decreased life expectancy. Since these two conditions are closely related from the pathophysiological point of view, as well as its complications, it is important to analyze the nutritional approach to them, as this aspect is the cornerstone in the treatment and prevention of these two diseases.


REFERENCES

  1. 1.LeRoith D., Taylor S., Olefsky J. Diabetes Mellitus, Fundamentos y Clínica. Mc Graw Hill. México, DF., 2003. Capítulos 76, 95 y 100, págs. 945-950, 1191 y 1245.

  2. 2.Casanova E, et al. Nutriología Médica. Segunda Edición. Editorial Médica Panamericana. México, D.F., 2001. Págs. 284,297-302, 370, 373, 377 y 378- 380.

  3. 3.Canizales S. Aspectos genéticos de la obesidad humana. Revista de Endocrinología y Nutrición 2008; Vol. 16, No. 1, pp 9-15.

  4. 4.Bellisari A. Evolutionary origins of obesity. Obes Rev. 2008 Mar;9(2):165-80.

  5. 5.Gutiérrez J. G. Meléndez G. Zúñiga A. Serralde A. Genómica nutricional y obesidad. Revista de Endocrinología y Nutrición 2006;14( 4):247-256.

  6. 6.McCarthy MI. Genomics, Type 2 Diabetes, and Obesity. N Engl J Med 2010;363:2339-50.

  7. 7.Musso G, Gambino R, Cassader M. Obesity, Diabetes, and Gut Microbiota. Diabetes Care. 2010 Oct;33(10):2277-84.

  8. 8.Mataix J. Nutrición y Alimentación Humana. Editorial ergon. Madrid, España, 2002. Volumen II, Capítulos 45 y 48, págs. 1097-1103 y 1172-1181.

  9. 9.Wilcox G. Insulin and Insulin Resistance. Clin Biochem Rev May 2005;26.

  10. 10.Abboud H, Henrich WL. Stage IV Chronic Kidney Disease. N Engl J Med 2010;362:56-65.

  11. 11.Alfenas R.C. Mattes R. Influence of Glycemic Index/Load on Glycemic Response, Appetite, and Food Intake in Healthy Humans. Diabetes Care 2005; 28:2123–2129.

  12. 12.Jenkins D, Kendall C, McKeown-Eyssen G, et al. Effect of a Low Glycemic Index or a High–Cereal Fiber Diet on Type 2 Diabetes; A Randomized Trial. JAMA. 2008; 300(23):2742-2753.

  13. 13.Pérez E, Serralde AE, Meléndez G. Efectos benéficos y deletéreos del consumo de fructosa. Revista de Endocrinología y Nutrición 2007; Vol. 15, No. 2, pp 67-74.

  14. 14.Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I. Tolllike receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 2009;50:1094–1104.

  15. 15.Madero M, Perez-Pozo SE, Jalal D, Johnson RJ, Sánchez-Lozada LG. Dietary fructose and hypertension. Curr Hypertens Rep. 2011 Feb;13(1):29-35.

  16. 16.Patel P, Sharp S, Luben R, et al. Association Between Type of Dietary Fish and Seafood Intake and the Risk of Incident Type 2 Diabetes. Diabetes Care 2009; 32:1857–1863.

  17. 17.NCEP. Executive Summary of the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment in High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2487-2497

  18. 18.Wang ZQ, Cefalu WT. Current concepts about chromium supplementation in type 2 diabetes and insulin resistance. Curr Diab Rep. 2010 Apr;10(2):145- 51.

  19. 19.Jolien de J, Kooy A, Lehert P, Wulffele M, Jan van der K, Bets D, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomized placebo controlled trial. BMJ 2010;340:c2181.

  20. 20.Sharabi A, Cohen E, Sulkes J, Garty M. Replacement therapy for vitamin B12 deficiency: comparison between the sublingual and oral route. Br J Clin Pharmacol. 2003 Dec;56(6):635-8.

  21. 21.Joergensen C, Gall MA, Schmedes A, Tarnow L, Parving HH, Rossing P. Vitamin D Levels and Mortality in Type 2 Diabetes. Diabetes Care 33:2238–2243, 2010.

  22. 22.Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–281.

  23. 23.Oh J, Weng S, Felton SK, Bhandare S, Riek A, Butler B, et al. 1,25(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009;120:687–698.

  24. 24.Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the reninangiotensin system. J Clin Invest 2002; 110:229–238.

  25. 25.Kenneth J, Darin J, Mark D. Stress-Response-Dampening Effects of Alcohol: Attention as a Mediator and Moderator. J Abnorm Psychol. 2007 May; 116(2): 362–377.

  26. 26.Laguna A. Sobrepeso y obesidad: Algoritmo de manejo nutricio. Revista de Endocrinología y Nutrición 2005;13( 2):94-105.

  27. 27.Laguna A. Sobrepeso: Estrategias para mejorar el manejo nutricio. Revista de Endocrinología y Nutrición 2006;14(2):102-113.

  28. 28.Cano-Rodríguez I, Ballesteros-Pomar MD, Pérez-Corral B, Aguado R. Dietas bajas en hidratos de carbono frente a dietas bajas en grasas. Endocrinol Nutr. 2006; 53(3):209-17.

  29. 29.Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, et al. Comparison of Weight Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates. N Engl J Med 2009;360:859-73.

  30. 30.Zafon C, Lecube A, Simó R. Iron in obesity. An ancient micronutrient for a modern disease. Obes Rev. 2010 Apr;11(4):322-8.

  31. 31.Monteiro R, Azevedo I. Chronic Inflammation in Obesity and the Metabolic Syndrome. Mediators Inflamm. 2010;2010. pii: 289645.

  32. 32.Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett 2008; 582: 97–105.

  33. 33.Guenter W, Lawrence TG. Anemia of Chronic Disease. N Engl J Med 2005;352:1011-23.

  34. 34.Astrup A, Finer N. Redefining Type 2 diabetes: 'Diabesity' or 'Obesity Dependent Diabetes Mellitus'?. Obes Rev. 2000 Oct;1(2):57-9.

  35. 35.Han TS, Richmond P, Avenell A, Lean MEJ. Waist circumference reduction and cardiovascular benefits during weight loss in women. Int J Obesity 1997; 21: 127–134.

  36. 36.Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481–486.

  37. 37.Haemer MA, Huang TT, Daniels SR. The effect of neurohormonal factors, epigenetic factors, and gut microbiota on risk of obesity. Prev Chronic Dis. 2009 Jul;6(3):A96.

  38. 38.Undurti ND. Obesity: Genes, brain, gut, and environment. Nutrition. 2010;26:459–473.

  39. 39.Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444(7122):1027-31.

  40. 40.Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. Changes in gut microbiota control metabolic endotoxemiainduced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008;57: 1470–1481.

  41. 41.Ghanim H, Abuaysheh S, Sia CL, Korzeniewski K, Chaudhuri A, Fer nandez-Real JM, Dandona P. Increase in plasma endotoxin concentrations and the expression of toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 2009;32:2281–2287.

  42. 42.Kalliomäki M, Collado MC, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 2008; 87:534–538.

  43. 43.Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006;118:511–521.

  44. 44.Penders J, Vink C, Driessen C, London N, Thijs C, Stobberingh EE. Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. FEMS Microbiol Lett 2005;243:141–147.

  45. 45.Gibson G, Probert H, Van Loo J, Rastall R, Roberfroid M. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev. 2004 Dec;17(2):259-75.

  46. 46.Bengmark S, Gil A. Control bioecológico y nutricional de la enfermedad: prebióticos, probióticos y simbióticos. Nutr Hosp 2006;21Supl2:73-86.

  47. 47.Quera R, Quigley E, Madrid AM. El rol de los prebióticos, probióticos y simbióticos en gastroenterología. Gastr Latinoam 2005; 16(3):218-228.

  48. 48.Oliveira G, González-Molero I. Probióticos y prebióticos en la práctica clínica. Nutr Hosp. 2007;22(Supl. 2):26-34.

  49. 49.Bosscher D, Breynaert A, Pieters L, Hermans N. Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects. J Physiol Pharmacol. 2009 Dec;60 Suppl 6:5-11.

  50. 50.Pal Kaur I, Kuhad A, Garg A, Chopra K. Probiotics: Delineation of Prophylactic and Therapeutic Benefits. J Med Food 2009;12(2):219–235.

  51. 51.Donaldson M. Nutrition and cancer: A review of the evidence for an anticancer diet. Nutr J. 2004 Oct 20;3:19.

  52. 52.Sanz Y, Collado M.C, Haros M, Dalmau J. Funciones metabolico nutritivas de la microbiota intestinal y su modulación a través de la dieta: probióticos y prebióticos. Acta Pediatrica Española 2004;62(11):520-526.

  53. 53.Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr. 2010 Aug;104 Suppl 2:S1-63.

  54. 54.Vitoria I. Probióticos, prebióticos y simbióticos. Pediatr Integral2007;XI(5):425-433.

  55. 55.Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with highnormal blood pressure or mild hypertension. J Am Coll Nutr 2005;24:257–265.

  56. 56.Marti del Moral A, Moreno J, Martínez JA. Efectos de los Prebióticos en el metabolismo lipídico. Nutr Hosp 2003;XVIII(4):181-188.

  57. 57.Sanz Y, Santacruz A, Dalmau J. Influencia de la microbiota intestinal en la obesidad y las alteraciones del metabolismo. Acta Pediatr Esp. 2009;67(9):437- 442.




2020     |     www.medigraphic.com